Pulmonary interstitial emphysema treated by high-frequency oscillatory ventilation

Critical Care Medicine
R H ClarkR A Delemos

Abstract

Twenty-seven low birth weight infants who developed pulmonary interstitial emphysema (PIE) and respiratory failure while on conventional ventilation were treated with high-frequency oscillatory ventilation (HFOV). The mean birth weight was 1.2 kg (range 0.55 to 2) with gestational age of 28 wk (range 25 to 34). Ten patients died, six of whom had documented sepsis with shock and were therefore excluded from analysis. All patients showed initial improvement on HFOV. Surviving patients showed continued improvement in oxygenation and ventilation at increasingly lower fraction of inspired oxygen and proximal airway pressure with resolution of PIE, while nonsurvivors progressively developed chronic respiratory insufficiency with continued PIE from which recovery was not possible. Overall survival in nonseptic patients was 80% (16 of 20). We found HFOV to be effective in the treatment of PIE and hypothesize that interstitial airleak is decreased during HFOV because adequate ventilation is provided at lower peak distal airway pressures.

Citations

Oct 6, 2000·Clinics in Chest Medicine·R G Brower, H E Fessler
Aug 1, 1995·Journal of Paediatrics and Child Health·D JohnstonB Timms
Apr 1, 1997·Journal of Paediatrics and Child Health·C A Ramsden, J J Pillow
Oct 21, 2000·BMJ : British Medical Journal·R GriffithsJ Struthers
Mar 1, 1997·Archives of Disease in Childhood. Fetal and Neonatal Edition·T F FokK W So
Sep 1, 1988·Journal of Medical Engineering & Technology·B Hayes
Sep 16, 2000·Chest·J A Krishnan, R G Brower
Aug 7, 1999·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·T Lockridge
Nov 9, 2004·Paediatric Respiratory Reviews·Kathleen M Ventre, John H Arnold
Jan 1, 1989·Acta Anaesthesiologica Scandinavica. Supplementum·A B Froese
Jan 1, 1989·Acta Anaesthesiologica Scandinavica. Supplementum·J J Coalson, R A deLemos
Jan 1, 1989·Acta Anaesthesiologica Scandinavica. Supplementum·F CortambertO Claris
Dec 1, 1996·The Tohoku Journal of Experimental Medicine·T SakaiK Iinuma
Mar 1, 1997·Acta Paediatrica·J Alexander, A D Milner
May 5, 2000·The Cochrane Database of Systematic Reviews·T Bhuta, D J Henderson-Smart
Jan 25, 2003·Critical Care Medicine·Dale Gerstmann
Feb 7, 1994·Journal of Intensive Care Medicine·J H Cronin
Sep 12, 2019·Archives of Disease in Childhood. Education and Practice Edition·Sagarika Ray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.